NO962125L - Anti-idiotypiske antistoffer som induserer en immunrespons mot epidermal vekstfaktorreseptor - Google Patents

Anti-idiotypiske antistoffer som induserer en immunrespons mot epidermal vekstfaktorreseptor

Info

Publication number
NO962125L
NO962125L NO962125A NO962125A NO962125L NO 962125 L NO962125 L NO 962125L NO 962125 A NO962125 A NO 962125A NO 962125 A NO962125 A NO 962125A NO 962125 L NO962125 L NO 962125L
Authority
NO
Norway
Prior art keywords
induce
growth factor
immune response
factor receptor
epidermal growth
Prior art date
Application number
NO962125A
Other languages
English (en)
Other versions
NO962125D0 (no
Inventor
Ana Carceller
Elisabet Rosell
Enrique Gomez
Jaume Adan
Jaume Piulats
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO962125D0 publication Critical patent/NO962125D0/no
Publication of NO962125L publication Critical patent/NO962125L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Foreliggende oppfinnelse ved- rører antiidiotypiske antistoffer som induserer en immunrespons mot tumorer, som bærer den epidermale vekstfaktor- reseptor (EGFR) som antigen. Antistof- fene ifølge oppfinnelsen kan etterligne antigenet. Som foretrukket utførelses- form er antistoffene ifølge oppfinnel- sen avledet fra mAb 425 (ATCC HB 9629) eller et humanisert eller kimært deri- vat derav.
NO962125A 1995-05-26 1996-05-24 Anti-idiotypiske antistoffer som induserer en immunrespons mot epidermal vekstfaktorreseptor NO962125L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95107967 1995-05-26

Publications (2)

Publication Number Publication Date
NO962125D0 NO962125D0 (no) 1996-05-24
NO962125L true NO962125L (no) 1996-11-27

Family

ID=8219291

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962125A NO962125L (no) 1995-05-26 1996-05-24 Anti-idiotypiske antistoffer som induserer en immunrespons mot epidermal vekstfaktorreseptor

Country Status (15)

Country Link
US (1) US5969107A (no)
JP (1) JPH08325299A (no)
KR (1) KR960040375A (no)
CN (1) CN1142505A (no)
AT (1) ATE208403T1 (no)
AU (1) AU710159B2 (no)
CA (1) CA2177328A1 (no)
CZ (1) CZ289357B6 (no)
DE (1) DE69616651D1 (no)
HU (1) HUP9601392A3 (no)
MX (1) MX9601930A (no)
NO (1) NO962125L (no)
PL (1) PL314414A1 (no)
SK (1) SK67496A3 (no)
ZA (1) ZA964207B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6924359B1 (en) * 1999-07-01 2005-08-02 Yale University Neovascular-targeted immunoconjugates
DK1358318T3 (da) * 2001-02-07 2007-01-02 Wilex Ag Hybridomcellelinje G250 og dens anvendelse til frembringelse af monoklonale antistoffer
WO2003092693A1 (en) * 2002-05-06 2003-11-13 Washington University Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway
KR101531400B1 (ko) 2003-06-27 2015-06-26 암젠 프레몬트 인코포레이티드 상피 성장 인자 수용체의 결실 돌연변이체 지향 항체 및 그용도
CA2671585A1 (en) * 2006-12-22 2008-07-03 Novelix Therapeutics Gmbh Treatment of diabetes by at least one epidermal growth factor receptor specific antibody or a derivative thereof
WO2011097633A2 (en) * 2010-02-08 2011-08-11 Board Of Regents, The University Of Texas System Egf receptor mimicking peptides
EP2663579B1 (en) 2011-01-14 2017-04-26 The Regents of the University of California Therapeutic antibodies against ror-1 protein and methods for use of same
CN109306010B (zh) * 2017-07-26 2022-07-19 石家庄以岭药业股份有限公司 表皮生长因子受体抗体及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141783B2 (en) * 1983-11-07 1993-06-16 The Wistar Institute Immune response to tumours and viruses induced by anti-idiotype antibodies
US4699880A (en) * 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
US4918164A (en) * 1987-09-10 1990-04-17 Oncogen Tumor immunotherapy using anti-idiotypic antibodies
US5459061A (en) * 1990-01-26 1995-10-17 W. Alton Jones Cell Science Center, Inc. Hybridomas producing monoclonal antibodies which specifically bind to continuous epitope on the human EGF receptor and compete with EGF for binding to the EGF receptor
CZ282603B6 (cs) * 1991-03-06 1997-08-13 Merck Patent Gesellschaft Mit Beschränkter Haftun G Humanizované a chimerické monoklonální protilátky
US5344760A (en) * 1991-06-03 1994-09-06 Ciba Corning Diagnostics Corp. Method of cancer detection
DE69327620T2 (de) * 1992-08-18 2000-08-03 Centro De Immunologia Molecular, Ciudad De La Habana Monoklonale Antikörper gegen den epidermalen Wachstumsfaktorrezeptor, Zellen und Verfahren zur ihrer Herstellung und sie erhaltende Zusammensetzungen

Also Published As

Publication number Publication date
CA2177328A1 (en) 1996-11-27
HU9601392D0 (en) 1996-07-29
ATE208403T1 (de) 2001-11-15
PL314414A1 (en) 1996-12-09
HUP9601392A3 (en) 2000-08-28
SK67496A3 (en) 1996-12-04
CZ152596A3 (en) 1996-12-11
JPH08325299A (ja) 1996-12-10
MX9601930A (es) 1997-01-31
US5969107A (en) 1999-10-19
HUP9601392A2 (en) 1997-03-28
ZA964207B (en) 1996-12-04
AU710159B2 (en) 1999-09-16
KR960040375A (ko) 1996-12-17
NO962125D0 (no) 1996-05-24
DE69616651D1 (de) 2001-12-13
AU5242296A (en) 1996-12-05
CZ289357B6 (cs) 2002-01-16
CN1142505A (zh) 1997-02-12

Similar Documents

Publication Publication Date Title
FI900332A0 (fi) Expressionssystem foer produktion av chimaera monoklonala antikroppar.
MX9504802A (es) Anticuerpos anti-egfr y fvs de cadena simple anti-egfr.
ATE153695T1 (de) Verfahren zur herstellung von antikörpern
ATE247168T1 (de) Humanisierte monoklonale antikörper
ATE233814T1 (de) Humaner neutralisierender monoklonaler antikörper gegen den die immunschwäche beim menschen hervorringenden virus
NO942912L (no) Konstruksjon, kloning og ekspresjon av humaniserte, monoklonale antistoffer mot humant interleukin-5
AU8567891A (en) Monoclonal antibody against melanoma
NO962125L (no) Anti-idiotypiske antistoffer som induserer en immunrespons mot epidermal vekstfaktorreseptor
DK407987D0 (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
EP0443599A3 (en) Monoclonal antibodies specific for tumor-associated antigens, method for their preparation and their use
DK0585570T3 (da) Granulocytbindende antistofkonstrukter, deres fremstilling og anvendelse
FI20095269A (fi) Lymfosyyttien sitoutumiseen vaikuttava ihmisen endoteelisolun molekyyli
DE69024758D1 (de) Neuartige antiidiotypische monoklonale Antikörper
DE59207362D1 (de) Monoklonale Antikörper gegen den Plasmin-Antiplasmin Komplex, Verfahren zu ihrer Herstellung sowie ihre Verwendung
CA2107329A1 (en) Anti-Human Immunodeficiency Virus Recombinant Antibodies
KR960701987A (ko) 단일클론 항체 88bv59, 서브클론 및 이들의 제조 방법(monoclonal antibody 88bv59, subclones and method of making)
RU96109830A (ru) Антиидиотипические антитела, которые индуцируют иммунный ответ против рецептора эпидермального фактора роста
NO900092D0 (no) Et ekspresjonssystem for fremstilling av kimeriske monoklonale antistoffer.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application